Literature DB >> 24662044

Chronic migraine.

Todd J Schwedt1.   

Abstract

Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine. Chronic migraine places an enormous burden on patients owing to frequent headaches; hypersensitivity to visual, auditory, and olfactory stimuli; nausea; and vomiting. It also affects society through direct and indirect medical costs. Chronic migraine typically develops after a slow increase in headache frequency over months to years. Several factors are associated with an increased risk of transforming to chronic migraine. The diagnosis requires a carefully performed patient interview and neurologic examination, sometimes combined with additional diagnostic tests, to differentiate chronic migraine from secondary headache disorders and other primary chronic headaches of long duration. Treatment takes a multifaceted approach that may include risk factor modification, avoidance of migraine triggers, drug and non-drug based prophylaxis, and abortive migraine treatment, the frequency of which is limited to avoid drug overuse. This article provides an overview of current knowledge regarding chronic migraine, including epidemiology, risk factors for its development, pathophysiology, diagnosis, management, and guidelines. The future of chronic migraine treatment and research is also discussed.

Entities:  

Mesh:

Year:  2014        PMID: 24662044     DOI: 10.1136/bmj.g1416

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  58 in total

1.  The effects of acute and preventive migraine therapies in a mouse model of chronic migraine.

Authors:  Alycia F Tipton; Igal Tarash; Brenna McGuire; Andrew Charles; Amynah A Pradhan
Journal:  Cephalalgia       Date:  2016-07-19       Impact factor: 6.292

2.  Cerebral venous hemodynamic abnormalities in episodic and chronic migraine.

Authors:  B Petolicchio; A Viganò; Lazzaro di Biase; D Tatulli; M Toscano; E Vicenzini; F Passarelli; V Di Piero
Journal:  Funct Neurol       Date:  2016 Apr-Jun

Review 3.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

Review 4.  Treatment Update of Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2017-06

Review 5.  Are Episodic and Chronic Migraine One Disease or Two?

Authors:  Reuben Burshtein; Aaron Burshtein; Joshua Burshtein; Noah Rosen
Journal:  Curr Pain Headache Rep       Date:  2015-12

6.  Pulsed radiofrequency of the C2 dorsal root ganglion and epidural steroid injections for cervicogenic headache.

Authors:  Shao-Jun Li; Dan Feng
Journal:  Neurol Sci       Date:  2019-03-07       Impact factor: 3.307

7.  Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.

Authors:  Jelena M Pavlovic; Justin S Yu; Stephen D Silberstein; Michael L Reed; Steve H Kawahara; Robert P Cowan; Firas Dabbous; Karen L Campbell; Anand R Shewale; Riya Pulicharam; Jonathan W Kowalski; Hema N Viswanathan; Richard B Lipton
Journal:  Cephalalgia       Date:  2019-03-09       Impact factor: 6.292

Review 8.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 9.  What Constitutes an "Adequate" Trial in Migraine Prevention?

Authors:  Jonathan H Smith; Todd J Schwedt
Journal:  Curr Pain Headache Rep       Date:  2015-11

10.  Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.

Authors:  Katja Kollewe; Claus M Escher; Dirk U Wulff; Davood Fathi; Lejla Paracka; Bahram Mohammadi; Matthias Karst; Dirk Dressler
Journal:  J Neural Transm (Vienna)       Date:  2016-03-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.